The U.S. Solution to China's Copper Grab
China consumes 54% of the world's copper. Yet China mines only 8% of its copper needs, while plundering Africa, Latin America and South America for copper. The U.S. is left scrambling for new copper sources. But there's a North American copper sweet spot overlooked by China – for now.
Find Out Where This Copper Hotspot Is
Douglas Evan Godshall, insider at ShockWave Medical

Douglas Evan Godshall Insider Information

Doug joined Shockwave as Chief Executive Officer in May 2017 to lead the company into US commercialization and international expansion.   This followed his most recent tenure as the CEO and a Director of HeartWare, a leader in the LVAD market. He managed the organization from a pre-commercial phase to over $250M in sales until it was acquired by Medtronic in August of 2016 for $1.1B.

Prior to HeartWare, Doug held other executive and leadership positions at Boston Scientific, including President of the Vascular Surgery Division, member of Boston Sci’s Operating Committee and Vice President of Business Development where he was responsible for more than 70 transactions, many in the arena of coronary and peripheral interventions.

Doug earned an MBA from Northeastern University and a BA in Economics from Lafayette College.

What is Douglas Evan Godshall's net worth?

The estimated net worth of Douglas Evan Godshall is at least $23.38 million as of May 13th, 2022. Mr. Godshall owns 142,926 shares of ShockWave Medical stock worth more than $23,376,977 as of May 17th. This net worth estimate does not reflect any other assets that Mr. Godshall may own. Additionally, Mr. Godshall receives an annual salary of $972,390.00 as CEO at ShockWave Medical. Learn More about Douglas Evan Godshall's net worth.

How old is Douglas Evan Godshall?

Mr. Godshall is currently 57 years old. There are 5 older executives and no younger executives at ShockWave Medical. Learn More on Douglas Evan Godshall's age.

What is Douglas Evan Godshall's salary?

As the CEO of ShockWave Medical, Inc., Mr. Godshall earns $972,390.00 per year. Learn More on Douglas Evan Godshall's salary.

How do I contact Douglas Evan Godshall?

The corporate mailing address for Mr. Godshall and other ShockWave Medical executives is 5403 Betsy Ross Drive, Santa Clara CA, 95054. ShockWave Medical can also be reached via phone at (510) 279-4262 and via email at [email protected] Learn More on Douglas Evan Godshall's contact information.

Has Douglas Evan Godshall been buying or selling shares of ShockWave Medical?

In the last ninety days, Douglas Evan Godshall has sold $2,863,050.00 in shares of ShockWave Medical stock. Most recently, Douglas Evan Godshall sold 5,000 shares of the business's stock in a transaction on Friday, May 13th. The shares were sold at an average price of $150.00, for a transaction totalling $750,000.00. Following the completion of the sale, the chief executive officer now directly owns 142,926 shares of the company's stock, valued at $21,438,900. Learn More on Douglas Evan Godshall's trading history.

Who are ShockWave Medical's active insiders?

ShockWave Medical's insider roster includes Colin Cahill (Director), Laura Francis (Director), Douglas Godshall (CEO), Antoine Papiernik (Director), Dan Puckett (CFO), Frank Watkins (Director), and Isaac Zacharias (Insider). Learn More on ShockWave Medical's active insiders.

Are insiders buying or selling shares of ShockWave Medical?

In the last year, insiders at the sold shares 50 times. They sold a total of 437,258 shares worth more than $76,711,299.40. The most recent insider tranaction occured on May, 13th when CEO Douglas Evan Godshall sold 5,000 shares worth more than $750,000.00. Insiders at ShockWave Medical own 15.3 % of the company. Learn More about insider trades at ShockWave Medical.

Information on this page was last updated on 5/13/2022.

Douglas Evan Godshall Insider Trading History at ShockWave Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/13/2022Sell5,000$150.00$750,000.00142,926View SEC Filing Icon  
5/11/2022Sell15,000$140.87$2,113,050.00142,926View SEC Filing Icon  
11/18/2021Sell45,000$207.28$9,327,600.00View SEC Filing Icon  
8/18/2021Sell45,000$188.08$8,463,600.00181,856View SEC Filing Icon  
5/18/2021Sell45,000$159.36$7,171,200.00181,856View SEC Filing Icon  
2/18/2021Sell45,000$121.96$5,488,200.00193,359View SEC Filing Icon  
11/17/2020Sell132,145$94.98$12,551,132.10230,083View SEC Filing Icon  
8/27/2020Sell849$60.00$50,940.0099,208View SEC Filing Icon  
8/24/2020Sell9,359$60.00$561,540.00107,718View SEC Filing Icon  
8/21/2020Sell16,750$60.02$1,005,335.00125,635View SEC Filing Icon  
8/4/2020Sell19,357$50.01$968,043.57109,002View SEC Filing Icon  
2/18/2020Sell30,000$43.23$1,296,900.0046,000View SEC Filing Icon  
11/21/2019Sell30,000$37.42$1,122,600.0046,000View SEC Filing Icon  
See Full Table

Douglas Evan Godshall Buying and Selling Activity at ShockWave Medical

This chart shows Douglas Evan Godshall's buying and selling at ShockWave Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ShockWave Medical Company Overview

ShockWave Medical logo
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $163.56
Low: $160.73
High: $170.33

50 Day Range

MA: $179.11
Low: $115.91
High: $214.48

2 Week Range

Now: $163.56
Low: $113.36
High: $249.73

Volume

701,063 shs

Average Volume

483,141 shs

Market Capitalization

$5.85 billion

P/E Ratio

212.42

Dividend Yield

N/A

Beta

1.5
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.